James Matcham MSc

James Matcham joined AstraZeneca in November 2013 as the Head of Early Clinical Development Biometrics. After completing his MSc in Statistics at Imperial College, London, he began his career as a Research Fellow at the Applied Statistics Research Unit at the University of Kent, UK working for 5 years in various applications of statistics but particularly in the area of clinical cross-over trials, linear and non-linear modelling and Bayesian methods. He then completed 21 years at Amgen where he worked on the development and regulatory/reimbursement approval of many of their biotechnology products, representing the company at regulatory submissions in the US and the EU. His last few years there were spent working to improve literature review, the use of adaptive and early phase design, network meta-analysis, Bayesian methods and quantitative decision making.

James has been a member of UK society for Pharmaceutical Statisticians (PSI) for over 25 years, serving on the Scientific and Training Committees as well as the Board of Directors. He has also served on the Professional Affairs Committee of the Royal Statistical Society and has been a Chartered Statistician of the Royal Statistical Society for over 20 years, and is currently a member of the Scientific Committee of the European Federation of Pharmaceutical Statistics.